西南军医
西南軍醫
서남군의
JOURNAL OF MILITARY SURGEON IN SOUTHWEST CHINA
2013年
2期
129-131
,共3页
廖常莉%周述之%赵晓蓉%姜鲜
廖常莉%週述之%趙曉蓉%薑鮮
료상리%주술지%조효용%강선
阿曲库铵%ED95%顺式阿曲库铵%时效
阿麯庫銨%ED95%順式阿麯庫銨%時效
아곡고안%ED95%순식아곡고안%시효
atracurium%ED95%cisatracurium%effective duration
目的观察预注小剂量阿曲库铵对不同ED95顺式阿曲库铵时效的影响.方法将80例ASAI-II级手术患者随机分为四组(n=20):A组3ED95(0.15 mg/kg)顺式阿曲库铵、B组4ED95(0.2 mg/kg)顺式阿曲库铵、C组预注射0.1 mg/kg阿曲库铵,复合3ED95顺式阿曲库铵、D组预注射0.1 mg/kg阿曲库铵,复合4ED95顺式阿曲库铵.观察各组顺式阿曲库铵起效时间、临床有效作用时间、术毕恢复时间;评估气管插管条件及不良反应.结果 B组与A组相比,B组顺式阿曲库铵起效时间无明显差异(P>0.05),而C、D两组起效时间较A、B组明显缩短(P<0.05),D组更短(P<0.05);有效作用时间B、D组较A、C组延长(P<0.05),D组最长(P<0.05);术毕恢复时间B、D组较A、C组明显延长(P<0.05),D组恢复时间最长(P<0.05).A组行气管插管不满意,B组有1例轻微呛咳;C、D组气管插管条件满意.结论预注射小剂量(0.1 mg/kg)阿曲库铵复合4 ED95顺式阿曲库铵,肌松起效时间短,临床有效作用时间长,术毕恢复快,气管插管条件满意,不良反应少,适合临床推广.
目的觀察預註小劑量阿麯庫銨對不同ED95順式阿麯庫銨時效的影響.方法將80例ASAI-II級手術患者隨機分為四組(n=20):A組3ED95(0.15 mg/kg)順式阿麯庫銨、B組4ED95(0.2 mg/kg)順式阿麯庫銨、C組預註射0.1 mg/kg阿麯庫銨,複閤3ED95順式阿麯庫銨、D組預註射0.1 mg/kg阿麯庫銨,複閤4ED95順式阿麯庫銨.觀察各組順式阿麯庫銨起效時間、臨床有效作用時間、術畢恢複時間;評估氣管插管條件及不良反應.結果 B組與A組相比,B組順式阿麯庫銨起效時間無明顯差異(P>0.05),而C、D兩組起效時間較A、B組明顯縮短(P<0.05),D組更短(P<0.05);有效作用時間B、D組較A、C組延長(P<0.05),D組最長(P<0.05);術畢恢複時間B、D組較A、C組明顯延長(P<0.05),D組恢複時間最長(P<0.05).A組行氣管插管不滿意,B組有1例輕微嗆咳;C、D組氣管插管條件滿意.結論預註射小劑量(0.1 mg/kg)阿麯庫銨複閤4 ED95順式阿麯庫銨,肌鬆起效時間短,臨床有效作用時間長,術畢恢複快,氣管插管條件滿意,不良反應少,適閤臨床推廣.
목적관찰예주소제량아곡고안대불동ED95순식아곡고안시효적영향.방법장80례ASAI-II급수술환자수궤분위사조(n=20):A조3ED95(0.15 mg/kg)순식아곡고안、B조4ED95(0.2 mg/kg)순식아곡고안、C조예주사0.1 mg/kg아곡고안,복합3ED95순식아곡고안、D조예주사0.1 mg/kg아곡고안,복합4ED95순식아곡고안.관찰각조순식아곡고안기효시간、림상유효작용시간、술필회복시간;평고기관삽관조건급불량반응.결과 B조여A조상비,B조순식아곡고안기효시간무명현차이(P>0.05),이C、D량조기효시간교A、B조명현축단(P<0.05),D조경단(P<0.05);유효작용시간B、D조교A、C조연장(P<0.05),D조최장(P<0.05);술필회복시간B、D조교A、C조명현연장(P<0.05),D조회복시간최장(P<0.05).A조행기관삽관불만의,B조유1례경미창해;C、D조기관삽관조건만의.결론예주사소제량(0.1 mg/kg)아곡고안복합4 ED95순식아곡고안,기송기효시간단,림상유효작용시간장,술필회복쾌,기관삽관조건만의,불량반응소,괄합림상추엄.
Objective To observe the affection of pre-injection of atracurium in small dosage on the age of ED95 of cisatracurium of different dosages. Methods 80 cases of ASAI II for surgery were randomly divided into 4 groups, 20 cases in each:Group A with 3 ED95 of cisatracurium(0.15mg/kg), Group B with 4 ED95 of cisatracurium(0.2mg/kg), Group C with pre-injection of atracurium(0.1mg/kg)plus 3ED95 of cisatracurium and Group D with pre-injection of atracurium(0.1mg/kg)plus 4ED95 of cisatracurium;an observation was made to the onset time, the effective duration and the time for recovery after operation in each group and the tracheal intubation con-dition and side-effects were estimated. Results There existed no obvious difference in the onset time of atracurium between Group A and Group B(P<0.05)while the onset time of Group C and of Group D was shorter than those of Group A and Group B(P<0.05), the onset time of Group D was the shortest(P<0.05);the effective duration of Group B and of Group D was longer than those of Group A and Group D(P<0.05), the effective duration of Group D was the longest(P<0.05);the time for recovery after operation in Group B and in Group D was obviously longer than those in Group A and Group C(P<0.05)and it took the longest in Group D(P<0.05);tra-cheal intubation condition in Group A was unsatisfactory, and 1 case suffered from slight cough in Group B while the tracheal intuba-tion condition in Group C and in Group D was good. Conclusions Pre-injection of atracurium in small dosage(0.1mg/kg)plus 4ED95 of cisatracurium can make the onset time shorter, clinical effective duration longer, recovery after operation quicker, tracheal intubation condition more satisfactory and less side effects, which is worthy of wide application in clinic.